Integrated discovery of SBLR876: a potent RAGE inhibitor mitigating AGE–RAGE–NF-κB-mediated cytotoxicity and inflammation in diabetic kidney disease
Fields of Study & Subjects
Advanced Glycation End Products research
Inflammation biomarkers and pathways
Clusterin in disease pathology
Publication details
- Journal / source
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Volume
- 811
- Pages
- 153540–153540
- Publication date
- 5 March 2026
- Language
- EN